Uchmanowicz Izabella, Nessler Jadwiga, Gobbens Robbert, Gackowski Andrzej, Kurpas Donata, Straburzynska-Migaj Ewa, Kałuzna-Oleksy Marta, Jankowska Ewa A
Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland.
Department of Coronary Heart Disease, Institute of Cardiology, Jagiellonian University Medical College, The John Paul II Hospital, Krakow, Poland.
Front Physiol. 2019 Jul 3;10:791. doi: 10.3389/fphys.2019.00791. eCollection 2019.
People over 65 years of age constitute over 80% of patients with heart failure (HF) and the incidence of HF is 10 per 1,000 in people aged above 65 years. Approximately 25% of older patients with HF exhibit evidence of frailty. Frail patients with cardiovascular disease (CVD) have a worse prognosis than non-frail patients, and frailty is an independent risk factor for incident HF among older people. Planning the treatment of individuals with HF and concomitant frailty, one should consider not only the limitations imposed by frailty syndrome (FS) but also those associated with the underlying heart disease. It needs to be emphasized that all patients with HF and concomitant FS require individualized treatment.
65岁以上的人群占心力衰竭(HF)患者的80%以上,65岁以上人群中HF的发病率为千分之十。约25%的老年HF患者表现出虚弱迹象。患有心血管疾病(CVD)的虚弱患者比非虚弱患者预后更差,虚弱是老年人发生HF的独立危险因素。在规划HF合并虚弱患者的治疗时,不仅应考虑虚弱综合征(FS)带来的限制,还应考虑与潜在心脏病相关的限制。需要强调的是,所有HF合并FS的患者都需要个体化治疗。